Consilium MedicumConsilium Medicum2075-17532542-2170Consilium Medicum91700Research ArticleEUROPA otkryvaet novye gorizonty primeneniya ingibitorov APFTereshchenkoS. N-1511200351166466628122021Copyright © 2003, Consilium Medicum2003ишемическая болезнь сердцастенокардияишемия миокардаингибиторы АПФ[Bertrand M.E, Van Belle E. Medicographia 2001; 23: 27-32.][Yusuf S, Lonn E. Eur Heart J 1998; 19 (suppl. J): J36-J44.][Rationale for the use of perindopril in the EUROPA study.//EUROPA. Publications & press releases. Press Conference, August 25, 1998 20th European Society of Cardiology meeting, Vienna. P.6.][Rolland P.H, Charpiot P et al. Am J Cardiol 1993; 71: 22E-27E.][Fennessy P.A, Campbell J.H et al. Clin Exp Pharmacol Physiol 1996; 23 (suppl. 1): S30-S32.][Vitorec J, Spinar J, Kinvesting C, Kinvesting S. Eur J Heart Failure 2000; 2: 299-304.][Моисеев В.С., Терещенко С.Н., Лександирия Л.Г., Кобалава Ж.Д. Тер. арх. 2001; 9: 66-73.][Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease^ randomized, double - blind, placebo - controlled, multicentre trial (the EUROPA study). Lancet 2003; 362: 782-8.]